WO2008099083A3 - Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives - Google Patents
Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives Download PDFInfo
- Publication number
- WO2008099083A3 WO2008099083A3 PCT/FR2008/000014 FR2008000014W WO2008099083A3 WO 2008099083 A3 WO2008099083 A3 WO 2008099083A3 FR 2008000014 W FR2008000014 W FR 2008000014W WO 2008099083 A3 WO2008099083 A3 WO 2008099083A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- neurodegenerative diseases
- treating neurodegenerative
- neuroprotective compounds
- obtaining drugs
- drugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008214550A AU2008214550A1 (en) | 2007-01-05 | 2008-01-04 | Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
CA002674100A CA2674100A1 (fr) | 2007-01-05 | 2008-01-04 | Utilisation de composes neuroprotecteurs pour l'obtention de medicaments destines au traitement de maladies neurodegeneratives |
JP2009544434A JP2010514827A (ja) | 2007-01-05 | 2008-01-04 | 神経変性疾患を処置するための薬剤を得るための神経保護化合物の使用 |
BRPI0806275-7A BRPI0806275A2 (pt) | 2007-01-05 | 2008-01-04 | utilização de compostos neuroprotetores para a obtenção de medicamentos destinados ao tratamento de doenças neurodegenerativas |
US12/448,719 US20090298813A1 (en) | 2007-01-05 | 2008-01-04 | Use of neuroprotective compounds in obtaining medicaments intended for the treatment of neurodegenerating diseases |
CNA2008800017537A CN101578100A (zh) | 2007-01-05 | 2008-01-04 | 神经保护性化合物在制备用于治疗神经变性疾病的药物中的用途 |
KR1020097016380A KR20090104853A (ko) | 2007-01-05 | 2008-01-04 | 신경퇴행성 질환을 치료하는 약물을 수득하기 위한 신경보호 화합물의 용도 |
EA200900923A EA200900923A1 (ru) | 2007-01-05 | 2008-01-04 | Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний |
EP08761738A EP2101768A2 (fr) | 2007-01-05 | 2008-01-04 | Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives |
MX2009007198A MX2009007198A (es) | 2007-01-05 | 2008-01-04 | Uso de compuestos neuroprotectores para obtener medicamentos destinados al tratamiento de enfermedades neurodegenerativas. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0700048A FR2911143A1 (fr) | 2007-01-05 | 2007-01-05 | Utilisation de composes neuroprotecteurs pour l'obtention de medicaments destines au traitement de maladies neurodegeneratives. |
FR0700048 | 2007-01-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008099083A2 WO2008099083A2 (fr) | 2008-08-21 |
WO2008099083A3 true WO2008099083A3 (fr) | 2008-12-11 |
Family
ID=38309971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2008/000014 WO2008099083A2 (fr) | 2007-01-05 | 2008-01-04 | Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090298813A1 (fr) |
EP (1) | EP2101768A2 (fr) |
JP (1) | JP2010514827A (fr) |
KR (1) | KR20090104853A (fr) |
CN (1) | CN101578100A (fr) |
AR (1) | AR064749A1 (fr) |
AU (1) | AU2008214550A1 (fr) |
BR (1) | BRPI0806275A2 (fr) |
CA (1) | CA2674100A1 (fr) |
EA (1) | EA200900923A1 (fr) |
FR (1) | FR2911143A1 (fr) |
MA (1) | MA31032B1 (fr) |
MX (1) | MX2009007198A (fr) |
WO (1) | WO2008099083A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926077A1 (fr) * | 2008-01-04 | 2009-07-10 | Servier Lab | Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
JP6154282B2 (ja) * | 2013-10-03 | 2017-06-28 | 株式会社ファンケル | 神経幹細胞又は神経前駆細胞の増殖促進剤 |
CN111018802B (zh) * | 2019-12-03 | 2021-07-06 | 湖北大学 | 具有抗帕金森氏症的化合物、制备方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1979000319A1 (fr) * | 1977-11-25 | 1979-06-14 | Buzas Andre | Nouvelles indolo (2, 3-a) quinolizidines, leur preparation et leur utilisation therapeutique |
EP0658557A1 (fr) * | 1993-12-14 | 1995-06-21 | Adir Et Compagnie | Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
EP1470818A1 (fr) * | 2003-04-25 | 2004-10-27 | Neuro3D | Utilisation de dérivés de phénothiazine pipérazine pour la préparation d'un médicament ayant des effets neuroprotecteurs et/ou neurotrophiques sur le SNC et/ou SNP |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1566099A (zh) * | 2003-06-13 | 2005-01-19 | 中国科学院上海药物研究所 | 异喹啉-1,3,4-三酮类化合物、制备方法及其用途 |
-
2007
- 2007-01-05 FR FR0700048A patent/FR2911143A1/fr not_active Withdrawn
-
2008
- 2008-01-04 BR BRPI0806275-7A patent/BRPI0806275A2/pt not_active IP Right Cessation
- 2008-01-04 US US12/448,719 patent/US20090298813A1/en not_active Abandoned
- 2008-01-04 JP JP2009544434A patent/JP2010514827A/ja active Pending
- 2008-01-04 AR ARP080100031A patent/AR064749A1/es unknown
- 2008-01-04 EP EP08761738A patent/EP2101768A2/fr not_active Withdrawn
- 2008-01-04 CA CA002674100A patent/CA2674100A1/fr not_active Abandoned
- 2008-01-04 WO PCT/FR2008/000014 patent/WO2008099083A2/fr active Application Filing
- 2008-01-04 CN CNA2008800017537A patent/CN101578100A/zh active Pending
- 2008-01-04 MX MX2009007198A patent/MX2009007198A/es not_active Application Discontinuation
- 2008-01-04 EA EA200900923A patent/EA200900923A1/ru unknown
- 2008-01-04 KR KR1020097016380A patent/KR20090104853A/ko not_active Application Discontinuation
- 2008-01-04 AU AU2008214550A patent/AU2008214550A1/en not_active Abandoned
-
2009
- 2009-06-29 MA MA32053A patent/MA31032B1/fr unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1979000319A1 (fr) * | 1977-11-25 | 1979-06-14 | Buzas Andre | Nouvelles indolo (2, 3-a) quinolizidines, leur preparation et leur utilisation therapeutique |
EP0658557A1 (fr) * | 1993-12-14 | 1995-06-21 | Adir Et Compagnie | Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent |
EP1470818A1 (fr) * | 2003-04-25 | 2004-10-27 | Neuro3D | Utilisation de dérivés de phénothiazine pipérazine pour la préparation d'un médicament ayant des effets neuroprotecteurs et/ou neurotrophiques sur le SNC et/ou SNP |
Also Published As
Publication number | Publication date |
---|---|
CA2674100A1 (fr) | 2008-08-21 |
WO2008099083A2 (fr) | 2008-08-21 |
FR2911143A1 (fr) | 2008-07-11 |
KR20090104853A (ko) | 2009-10-06 |
EA200900923A1 (ru) | 2009-12-30 |
AR064749A1 (es) | 2009-04-22 |
CN101578100A (zh) | 2009-11-11 |
BRPI0806275A2 (pt) | 2011-09-06 |
JP2010514827A (ja) | 2010-05-06 |
MX2009007198A (es) | 2009-08-12 |
AU2008214550A1 (en) | 2008-08-21 |
EP2101768A2 (fr) | 2009-09-23 |
MA31032B1 (fr) | 2009-12-01 |
US20090298813A1 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2318005A4 (fr) | Agents neuroprotecteurs pour la prévention et le traitement de maladies neurodégénératives | |
HK1224200A1 (zh) | 用於治療胰腺癌的藥物 | |
ZA200703601B (en) | Medicaments for the treatment or prevention of fibriotic diseases | |
PL2118074T3 (pl) | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego | |
EP2166837A4 (fr) | Combinaison médicamenteuse utilisable pour le traitement de troubles cutanés | |
WO2007150077A8 (fr) | Immunogènes inducteurs de la production de lymphocytes t cytotoxiques utilisables en vue de la prévention, du traitement et du diagnostic du cancer | |
ZA200810531B (en) | Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown | |
EP2061503A4 (fr) | Immunogènes inducteurs de la production de lymphocytes t cytotoxiques pour la prévention, le traitement et le diagnostic du cancer | |
TNSN08400A1 (en) | Organic compounds and their uses | |
EP2099448A4 (fr) | Composition pharmaceutique pour le traitement et la prévention de la resténose | |
EP2421367A4 (fr) | Administration d'allantoïne pour le traitement d'une maladie neurodégénérative et d'un traumatisme neurologique | |
ZA201200944B (en) | Pharmaceutical compositions for the treatment of cancer and other diseases or disorders | |
EP2206714A4 (fr) | Agent destiné à la prévention et/ou au traitement de maladies cutanées | |
EP3685838A4 (fr) | Composé pour le traitement ou la prévention de l'obésité ou de maladies liées à l'obésité, et son application | |
HK1145994A1 (zh) | 苦瓜中提取的化合物在製備預防和治療糖尿病和肥胖的藥物中的用途 | |
IL201449A0 (en) | Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases | |
MX2010003269A (es) | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. | |
IL201562A0 (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases | |
EP2001488A4 (fr) | Prevention et traitement des cancers et d'autres maladies | |
IL210386A (en) | Indole history, their medicinal preparations, and their use in the preparation of drugs for the treatment or prevention of neurodegenerative diseases | |
EP2231148A4 (fr) | Composition pharmaceutique utilisée dans le traitement et la prévention d'une maladie cardiaque | |
EP2231146A4 (fr) | Composition pharmaceutique pour le traitement et la prévention du glaucome | |
EP2328877A4 (fr) | Composés de 1,4-benzoxazine, et dérivés de ceux-ci en tant que médicaments thérapeutiques pour le traitement de troubles neurodégénératifs | |
WO2008152068A3 (fr) | Dérivés de [1,10]-phénanthroline pour le traitement de maladies neurodégénératives ou hématologiques | |
WO2008099083A3 (fr) | Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880001753.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08761738 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008214550 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008761738 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2674100 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4319/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12448719 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 578125 Country of ref document: NZ Ref document number: MX/A/2009/007198 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2009544434 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009071037 Country of ref document: EG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008214550 Country of ref document: AU Date of ref document: 20080104 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11389 Country of ref document: GE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200900923 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097016380 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0806275 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090706 |